ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

CCOP 2 Under Way After Bitter Recompetition Cancer Control Protocols Being Review; PLs, Affiliates Listed

February 19, 1988

Vanderbilt-Ingram wins third SPORE grant.

September 19, 2003

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

Calcium, Vitamin D Provide No Benefit for Colon Cancer

February 24, 2006

Samuel Broder Plans To Leave Celera.

September 10, 2010

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008